The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis.

• van Es N Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.
• Ventresca M Michael G. DeGroote Cochrane Canada and McGRADE Centres, Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
• Di Nisio M Department of Medicine and Ageing Sciences, University G. D'Annunzio, Chieti-Pescara, Italy.
• Zhou Q Michael G. DeGroote Cochrane Canada and McGRADE Centres, Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
• Noble S Marie Curie Palliative Care Research Centre, Cardiff University, Wales, UK.
• Crowther M Michael G. DeGroote Cochrane Canada and McGRADE Centres, Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
• Briel M Michael G. DeGroote Cochrane Canada and McGRADE Centres, Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
• Garcia D Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
• Lyman GH Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
• Macbeth F Centre for Trials Research, School of Medicine, Cardiff University, Wales, UK.
• Griffiths G Centre for Trials Research, School of Medicine, Cardiff University, Wales, UK.
• Iorio A Michael G. DeGroote Cochrane Canada and McGRADE Centres, Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
• Mbuagbaw L Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.
• Neumann I Michael G. DeGroote Cochrane Canada and McGRADE Centres, Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
• Brozek J Michael G. DeGroote Cochrane Canada and McGRADE Centres, Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
• Guyatt G Michael G. DeGroote Cochrane Canada and McGRADE Centres, Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
• Streiff MB Division of Hematology, Department of Internal Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
• Baldeh T Michael G. DeGroote Cochrane Canada and McGRADE Centres, Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
• Florez ID Michael G. DeGroote Cochrane Canada and McGRADE Centres, Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
• Gurunlu Alma O Department of Statistics, Mugla Sitki Kocman University, Mugla, Turkey.
• Agnelli G Internal Vascular and Emergency Medicine-Stroke Unit, Università di Perugia, Perugia, Italy.
• Ageno W Department of Medicine and Surgery, University of Insubria, Varese, Italy.
• Marcucci M Michael G. DeGroote Cochrane Canada and McGRADE Centres, Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
• Bozas G Academic Department of Medical Oncology, Castle Hill Hospital, Cottingham, Hull University Teaching Hospitals NHS Trust, Cottingham, UK.
• Zulian G Department of Readaptation and Palliative Medicine, Geneva University Hospitals, Geneva, Switzerland.
• Maraveyas A Division of Cancer-Hull York Medical School, University of Hull, Hull, UK.
• Lebeau B Service de Pneumologie, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, Paris, France.
• Lecumberri R Hematology Service, University Clinic of Navarra, Pamplona, Spain.
• Sideras K Divisions of Medical Oncology, Cardiology and Hematology, Mayo Clinic, Rochester, MN, USA.
• Loprinzi C Divisions of Medical Oncology, Cardiology and Hematology, Mayo Clinic, Rochester, MN, USA.
• McBane R Divisions of Medical Oncology, Cardiology and Hematology, Mayo Clinic, Rochester, MN, USA.
• Pelzer U Division of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin Institute of Health, Freie Universität Berlin, Humboldt Universität-Universität zu Berlin, Berlin, Germany.
• Riess H Department of Hematology, Oncology, and Tumor Immunology, Charité, University Hospital, Berlin, Germany.
• Solh Z Transfusion Medicine Section, Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
• Perry J Division of Neurology, Sunnybrook Health Science Centre, Toronto, ON, Canada.
• Kahale LA Michael G. DeGroote Cochrane Canada and McGRADE Centres, Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
• Bossuyt PM Department of Clinical Epidemiology, Biostatistics, and Bioinformatics, Amsterdam Public Health Research Institute, Academic Medical Center, Amsterdam, The Netherlands.
• Klerk C Department of Internal Medicine, Dijklanderziekenhuis, Hoorn, The Netherlands.
• Büller HR Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.
• Akl EA Michael G. DeGroote Cochrane Canada and McGRADE Centres, Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
• Schünemann HJ Michael G. DeGroote Cochrane Canada and McGRADE Centres, Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.

Khorana score

cancer

heparin

individual participant data meta-analysis

thromboprophylaxis

venous thromboembolism